Progression from colorectal
adenoma to
carcinoma is strongly associated with an accumulation of genomic alterations, including gain of chromosome 13. This gain affects the whole q arm and is present in 40%-60% of all
colorectal cancers (
CRCs). Several genes located at this amplicon are known to be overexpressed in
carcinomas due to copy number dosage. A subset of these genes, including the mir-17~92 cluster, are functionally involved in CRC development. The present study set out to explore whether apart from mir-17~92, other
miRNAs located at the 13q amplicon show a copy number dependent dosage effect that may contribute to 13q-driven colorectal
adenoma-to-
carcinoma progression. Integration of publically available
miRNA expression, target
mRNA expression and
DNA copy number data from 125
CRCs yielded three
miRNAs, miR-15a, -17, and -20a, of which high expression levels were significantly correlated with a 13q gain and which influenced target
mRNA expression. These results could be confirmed by qRT-PCR in a series of 100 colon
adenomas and
carcinomas.Functional analysis of both mature
miRNAs encoded by mir-15a, i.e. miR-15a-5p and miR-15a-3p, showed that silencing of miR-15a-3p significantly inhibited viability of CRC cells. Integration of miR-15a expression levels with
mRNA expression data of predicted target genes identified
mitochondrial uncoupling protein 2 (UCP2) and
COP9 signalosome subunit 2 (COPS2) as candidates with significantly decreased expression in
CRCs with 13q gain. Upon silencing of miR-15a-3p,
mRNA expression of both genes increased in CRC cells, supporting miR-15a-3p mediated regulation of UPC2 and COPS2 expression. In conclusion, significant overexpression of miR-15a-3p due to gain of 13q is functionally relevant in CRC, with UCP2 and COPS2 as candidate target genes. Taken together our findings suggest that miR-15a-3p may contribute to
adenoma-to-
carcinoma progression.